Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1 . Years Considered for the Study
       3.2 . Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1 . Secondary Data
        1.1.1 . Key Data from Secondary Sources
       1.2 . Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Hospital Acquired Infection Control Market Variables, Trends and Scope

  •   1. Market LineProducts Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Hospital Acquired Infection Control Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Hospital Acquired Infection Control Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Hospital Acquired Infection Control Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Sterilizers
      2. Disinfectors
      3. Endoscope Reprocessors
      4. Disinfectants
       4.1. Disinfectants Market, By Product
        4.1.1. Hand Disinfectants
        4.1.2. Skin Disinfectants
        4.1.3. Instrument Disinfectants
        4.1.4. Surface Disinfectants/Disinfectant Robots
       4.2. Disinfectants Market, By Formulation
        4.2.1. Disinfectant Wipes
        4.2.2. Disinfectant Liquids
        4.2.3. Disinfectant Sprays
      5. Medical Nonwovens

• 8.   Hospital Acquired Infection Control Market, By Testing Market Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. By Product
       1.1. Microbial Testing Instruments
        1.1.1. Automated Microbial Identification Systems
        1.1.2. Polymerase Chain Reaction (PCR) Instruments
        1.1.4. Mass Spectrometers
        1.1.5. Microarrays
        1.1.6. Polystainers
        1.1.7. Flow Cytometers
        1.1.8. Others
       1.2. Reagents and Consumables
       1.3. Infection Prevention and Surveillance Software
      2. By Application
       2.1. Disease Testing
       2.2. Drug-Resistance Testing
      3. By Technology
       3.1. Phenotypic Methods
        3.1.1. Phage-Based Assays
        3.1.2. Colorimetric Methods
        3.1.3. The Nitrate Reductase Assay
       3.2. Genotypic Methods
        3.2.1. Dna Sequencing
        3.2.2. Solid-Phase Hybridization Techniques
        3.2.3. Polymerase Chain Reaction Techniques
        3.2.4. Microarrays 5
      4. By Disease
       4.1. Hospital Acquired Pneumonia
       4.2. Bloodstream Infections
       4.3. Surgical Site Infections
       4.4. Gastrointestinal Infections
       4.5. Urinary Tract Infections (UTI)
       4.6. Others

• 9.   Hospital Acquired Infection Control Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Hospitals and Intensive Care Units (ICUS)
      2. Ambulatory Surgical and Diagnostic Centers
      3. Nursing Homes and Maternity Centers
      4. Others

• 10.   North America Hospital Acquired Infection Control Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2023-2031

• 11.   Latin America Hospital Acquired Infection Control Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Brazil
       2.2. Venezuela
       2.3. Argentina
       2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2023-2031

• 12.   Europe Hospital Acquired Infection Control Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Germany
       2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031

• 13.   Asia Pacific Hospital Acquired Infection Control Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

• 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. GCC
       2.2. Israel
       2.3. South Africa
       2.4. Rest of MEA
      3. Market Size (USD Million) Forecast for MEA 2023-2031

• 15.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •   1. Becton, Dickinson and Company
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. Steris Corporation
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Advanced Sterilization Products
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Getinge Group
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Kimberly-Clark Corporation
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Cantel Medical
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. BioMérieux SA
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. Belimed AG
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. 3M company
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
      10. Sterigenics International LLC.
       10.1. Company Overview
       10.2. Product Portfolio
       10.3. SWOT Analysis
       10.4. Financial Overview
       10.5. Strategic Overview
      11. Synergy Health, plc
       11.1. Company Overview
       11.2. Product Portfolio
       11.3. SWOT Analysis
       11.4. Financial Overview
       11.5. Strategic Overview

• 17.   Pre and Post COVID-19 Impact

  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by
                administrations
      5. The overall economic slowdown of the developing and developed nations

• 18.   FutureWise SME Key Takeaway Points for Client